Beth Shaz, MD, has started her term as president of AABB (formerly the American Association of Blood Banks). Dr. Shaz, who will be president for the 2019-2020 term, was inaugurated during the 2019 AABB annual meeting. She succeeds Michael Murphy, MD, as president.
Dr. Beth Shaz
Dr. Shaz is the executive vice president and chief medical and scientific officer at the New York Blood Center in New York. She is a scientific member of Biomedical Excellence for Safer Transfusion, an associate editor of Transfusion, and an editorial board member of Blood. She received her medical degree from University of Michigan in Ann Arbor and a bachelor’s degree in chemical engineering from Cornell University in Ithaca, N.Y.
AABB also has a new president-elect, David Green. Mr. Green is president and chief executive officer of Vitalant, and he is based in Scottsdale, Ariz. Mr. Green previously led the Vitalant blood services division. Before that, he was president and chief executive officer of Mississippi Valley Regional Blood Center in Davenport, Iowa.
David Green
Mr. Green has served as chairman of Blood Centers of America and president of America’s Blood Centers. He earned a bachelor’s degree from Knox College in Gallesburg, Ill., and a master’s degree from Central Michigan University in Mount Pleasant, Mich.
Dana Devine, PhD, is the new vice president of AABB. Dr. Devine is the chief medical and scientific officer at Canadian Blood Services. She is also a professor at the University of British Columbia in Vancouver and a founding member of the university’s Centre for Blood Research.
Dr. Dana Devine
Dr. Devine’s research is focused on platelet biology, complement biochemistry, coagulation, and blood product processing and storage. Dr. Devine is the editor in chief of Vox Sanguinis. She earned her PhD from Duke University in Durham, N.C.
Steven Sloan, MD, PhD, is the new secretary of AABB. Dr. Sloan is an associate professor at Harvard Medical School in Boston and blood bank medical director at Children’s Hospital Boston.
Dr. Steven Sloan
Dr. Sloan’s research is focused on intracellular signaling and transcription regulation in B cells during immune responses. Dr. Sloan attended medical school at New York University in New York, and completed his residency and fellowship at the Hospital of the University of Pennsylvania in Philadelphia.